“FINAL HEIGHT AND ENDOCRINE COMPLICATIONS IN PATIENTS WITH ?-THALASSSEMIA INTERMEDIA: OUR EXPERIENCE IN NON-TRANSFUSED VERSUS INFREQUENTLY TRANSFUSED PATIENTS AND CORRELATIONS WITH LIVER IRON CONTENT: None” (2019) Mediterranean Journal of Hematology and Infectious Diseases, 11(1), p. e2019026. doi:10.4084/mjhid.2019.026.